Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Eiger Biopharma (NQ: EIGR )

11.02 USD -0.84 (-7.08%)
Official Closing Price Updated: 4:01 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Eiger Biopharma

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Eiger BioPharmaceuticals Announces EMA Validation of Lonafarnib MAA for Treatment of Progeria and Progeroid Laminopathies
- Accelerated Assessment of MAA Previously Granted by EMA in March 
From PR Newswire
Add Up The Pieces: URTY Could Be Worth $26
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
76 Biggest Movers From Yesterday
Gainers ION Geophysical Corporation (NYSE: IO) shares climbed 94% to close at $2.25 on Thursday after the company reported ... 
Tags DCP CDE Airlines
From Benzinga
60 Stocks Moving In Thursday's Mid-Day Session
Gainers ION Geophysical Corporation (NYSE: IO) shares jumped 77.2% to $2.0550 after the company reported announced preliminary Q1 ... 
Tags TALO Energy OVV
From Benzinga
The Daily Biotech Pulse: Novartis Scraps Deal To Sell Sandoz Assets, Nevro Pre-Announces Q1 Shortfall, Affimed Granted Orphan Drug Designation
Here's a roundup of top developments in the biotech space over the last 24 hours. On a day when the three major averages shed ... 
Tags Market News VIR HGEN
From Benzinga
Eiger BioPharmaceuticals Provides Update on Clinical Development Activities and Business Operations During COVID-19 Pandemic
- HDV Phase 3 D-LIVR Study Progressing; Impact to Timeline 
From PR Newswire
Eiger BioPharmaceuticals Completes Submission of New Drug Application to FDA for Lonafarnib for Treatment of Progeria and Progeroid Laminopathies
- Progeria MAA Submitted to EMA and Granted Accelerated Assessment 
From PR Newswire
Stocks That Hit 52-Week Lows On Monday
On Monday, 2568 stocks hit new 52-week lows. Areas of Significance: Amazon.com(NASDAQ: AMZN)is the largest company ... 
Tags HCFT EVR CRSA
From Benzinga
Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
- Progeria MAA Submission Completed and Accelerated Assessment Granted by EMA 
From PR Newswire
Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning session, various companies made new 52-week lows. Intriguing Points: Facebook(NASDAQ: ... 
Tags NTAP ESSA NRIM
From Benzinga
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags INO EVFM HARP
From Benzinga
The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Market News CAPR AFMD
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's morning session saw 216 companies set new 52-week lows. Intriguing Points: Ambev(NYSE: ABEV)was the ... 
Tags ACC EAT TGLS
From Benzinga
The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ... 
Tags JAGX BLUE SYBX
From Benzinga
The Daily Biotech Pulse: Breakthrough Device Designation For Neuronetics, AbbVie Receives European Label Expansion, AstraZeneca Flunks Late-Stage Study
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ... 
Tags GKOS ETON MTEM
From Benzinga
Look Under The Hood: VTWO Has 25% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning session, 353 stocks hit new 52-week lows. Areas of Significance: The largest company by market ... 
Tags GCO ENLV HAL
From Benzinga
EIGR Makes Notable Cross Below Critical Moving Average
In trading on Friday, shares of Eiger BioPharmaceuticals Inc (EIGR) crossed below their 200 day moving average of $11.49, changing hands as low as $11.36 per share. Eiger BioPharmaceuticals Inc shares... 
Tags Stocks
From Market News Video
Analysts Expect UWM To Hit $83
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Pick Up This Bargain Even Cheaper Than Director Dietz Did
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on January 10, Eiger BioPharmaceuticals Inc's Director,... 
Tags Stocks
From Market News Video
Monday 1/13 Insider Buying Report: EDSA, EIGR
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their... 
Tags Stocks
From Market News Video
Eiger BioPharmaceuticals Appoints Industry Veteran Eldon Mayer as Executive Vice President and Chief Commercial Officer
- Launch Preparation Underway for Lonafarnib in Progeria 
From PR Newswire
Eiger Updates on 2019 Progress and 2020 Milestones Expected
- Progeria Rolling NDA Planned for Completion in 1Q 2020 
From PR Newswire
Analysts Forecast 17% Gains Ahead For The Holdings of BIB
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Flexion Receives FDA Nod For Zilretta Label Expansion, Astellas Goes Shopping
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech ... 
Tags NEO REPH BOLD
From Benzinga
The Daily Biotech Pulse: Qiagen Opts To Stay Solo Following Strategic Review, Spectrum Slumps On Negative Data, Microbot Medical To Offer Shares
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that ... 
Tags OYST AGTC DRRX
From Benzinga
51 Biggest Movers From Tuesday
Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares jumped 61% to close at $16.28 on Tuesday after surging 77.37% on ... 
Tags CVM General IFRX
From Benzinga
Eiger Initiates Rolling Submission of New Drug Application (NDA) with FDA for Lonafarnib for Treatment of Progeria and Progeroid Laminopathies
- Rolling NDA Submission Planned for Completion in First Quarter 2020 
From PR Newswire
Eiger to Present at Jefferies 2019 London Healthcare Conference
Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that Eiger management... 
From PR Newswire
81 Biggest Movers From Yesterday
Gainers IDEAYA Biosciences, Inc. (NASDAQ: IDYA) shares rose 47.3% to close at $8.50 on Wednesday after reporting Q3 ... 
Tags Movers & Shakers IRTC ELMD
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.